Graviti Pharmaceuticals` Generic Chlorzoxazone Receives Approval in the U.S.
CorePharma's Generic Chlorzoxazone Receives Approval in the U.S.
Enforcement Report - Week of September 29, 2021
Havix`s Generic Chlorzoxazone Receives Tentative Approval In US
I3 Pharms's Generic Chlorzoxazone Receives Approval In US
Mayne Pharma’s Generic Chlorzoxazone Receives Approval In US
ADELAIDE, Australia, July 27, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for chlorzoxazone tablet, 375 mg, 500 mg and 750 mg, in the United States. Mayne Pharma has commenced commercial launch activities to customers in the US.
ADELAIDE, Australia, July 27, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for chlorzoxazone tablet, 375 mg, 500 mg and 750 mg, in the United States. Mayne Pharma has commenced commercial launch activities to customers in the US.
ADELAIDE, Australia, July 27, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for chlorzoxazone tablet, 375 mg, 500 mg and 750 mg, in the United States. Mayne Pharma has commenced commercial launch activities to customers in the US.